CA184-043: A randomized, double-blind, phase III trial comparing ipilimumab versus placebo following a single dose of radiotherapy (RT) in patients (pts) with castration-resistant prostate cancer (CRPC) who have received prior treatment with docetaxel (D) Meeting Abstract
| Authors: | Drake, C. G.; Scher, H. I.; Bossi, A.; van den Eertwegh, A. J. M.; McHenry, B.; Fitzmaurice, T. F.; Cuillerot, J. M.; Chin, K. M.; Gagnier, P.; Fizazi, K.; Gerritsen, W. R. |
| Abstract Title: | CA184-043: A randomized, double-blind, phase III trial comparing ipilimumab versus placebo following a single dose of radiotherapy (RT) in patients (pts) with castration-resistant prostate cancer (CRPC) who have received prior treatment with docetaxel (D) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009802665 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.TPS4689 |
| Notes: | Meeting Abstract: TPS4689 -- Source: Wos |
